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Abstract
Background—Limited information exists regarding the long-term development of comorbidity
between Major Depressive Disorder (MDD) and Alcohol Use Disorder (AUD; abuse/dependence).
Using a representative prospective study, we examine multiple aspects pertaining to MDD+AUD
comorbidity, with a focus on the relation between disorders across periods (adolescence, early
adulthood, adulthood) and cumulative impairments by age 30.
Method—816 participants were diagnostically interviewed at ages 16, 17, 24, and 30.
Results—Rates of comorbid MDD+AUD were low in adolescence (2%), but increased in early
adulthood (10%) and adulthood (7%). Rates of cumulative comorbidity were elevated (21%).
Most individuals with a history of MDD or AUD had the other disorder, except for women with
MDD. Prospectively, adolescent AUD predicted early adult MDD, while early adult MDD
predicted adult AUD. Compared to pure disorders, MDD+AUD was associated with higher risk of
alcohol dependence, suicide attempt, lower global functioning, and life dissatisfaction.
Conclusions—Lifetime rates of comorbid MDD+AUD were considerably higher than in cross-
sectional studies. Comorbidity was partly explained by bidirectional and developmentally-specific
associations and predicted selected rather than generalized impairments. Clinically, our findings
emphasize the need to always carefully assess comorbidity in patients with MDD or AUD, taking
into account concurrency and developmental timing.
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Introduction
Comorbidity between Major Depressive Disorder (MDD) and Alcohol Use Disorder (AUD;
abuse or dependence) represents one of the most prevalent and disabling psychiatric
combinations in adolescence and adulthood. In the last decades, clinical and epidemiological
studies have documented the rates and characteristics of MDD+AUD comorbidity,
especially in adulthood (1-5). Although longitudinal studies have investigated associations
between the two disorders, none has comprehensively examined the development and
implications of comorbidity from adolescence to adulthood. Here, we use a prospective
sample of participants followed to age 30 to investigate several key issues of comorbidity
(6) applying to MDD+AUD.
Our first focus is on the relation between the two disorders. Using two complimentary
angles, we analyze the temporal ordering and predictions between MDD and AUD across
key developmental periods. Evidence on temporal ordering from retrospective studies has
been mixed, with studies reporting MDD to most often precede AUD (1, 7, 8), AUD to most
often predece MDD (9) or no clear ordering (2, 10). Similarly, predictions between disorders
have been conflicting. Prospective studies have found MDD to predict AUD (8, 11), AUD to
predict MDD (12, 13), bidirectional relations (9, 14, 15) and no association between the two
disorders after controlling for confounders (16). A key limitation of the literature is that
most evidence comes from adult samples of wide age ranges (8, 9, 11, 14-16), making it
difficult to determine whether associations vary across developmental periods.
Our second focus is on “cumulative comorbidity”, which indexes lifetime rather than point
co-occurrence of disorders (17). We examine the implications of having lifetime patterns
with or without overlapping disorders (concurrent vs. successive comorbidity) (6). Very
little information is available to document these types of comorbidity. We also investigate
clinical and psychosocial impairments associated with lifetime comorbid MDD+AUD
compared to pure MDD and AUD. Greater impairments have typically been reported in
comorbid individuals (e.g., more persistent and severe disorders, suicide risk, lower social
adjustment) (1, 4, 18-20), but other studies found no poorer or less adverse outcomes of
comorbidity, notably lower AUD severity compared to pure AUD (21, 22). We also
consider whether impairments vary as a function of both concurrency or temporal ordering
(MDD-first vs. AUD-first). To our knowledge, no prospective study has previously
examined cumulative impairments of MDD+AUD in adulthood.
We use data from the Oregon Adolescent Depression Project (OADP) (23) to address these
questions. The OADP is unique in combining 4 prospective assessment waves from
adolescence to adulthood paired with retrospective recall between assessments, providing
diagnostic coverage up to age 30. This design compares favorably to most prospective
studies, which have more limited coverage, as well as retrospective studies, which are
impacted by long-term recall bias. In keeping with the new DSM-5 (24), we investigate
AUD as a single disorder, rather than abuse and dependence as separate disorders. We do,
however, consider alcohol dependence as a marker of AUD severity.
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Method
Participants
OADP participants were followed at four time points (23). The sample was randomly
selected from nine high schools representative of western Oregon. After complete
description of the study to the participants, written informed consent was obtained. Ethics
approval was granted by the Oregon Research Institute. At T1, 1709 adolescents were
administered a diagnostic interview and questionnaires at an average age of 16.6 years
(SD=1.2). The sample was approximately equally-divided by gender (53% women) and
mostly White (91%). Participants were invited to complete a second assessment
approximately one year later. At T2, 1507 participants (88% of T1) returned for a second
assessment. A subset of participants was invited to a third assessment at age 24 (T3): all
participants with a history of psychopathology (N=555) and a randomly selected subset of
participants with no history of mental disorder (N=386); 941 participants (85% of those
invited) completed T3 assessments. All T3 participants were invited for a fourth wave at age
30; 816 participants (87% of T3) completed assessments at T4. The present study uses
OADP participants who completed assessments up to T4 (59% women; 89% White).
Differences between persons who continued and discontinued participation were overall
small (25). Correlates of discontinuation were male gender, cigarette and substance use, a
history of a disruptive behavior disorder, lower socioeconomic status, and fewer persons
living at home during adolescence.
Measures
Diagnoses of MDD and AUD, as well anxiety disorders, disruptive behavior disorders
(DBD), and other substance use disorders (SUD; excluding tobacco dependence) were
obtained from standardized diagnostic interviews. T1-T3 interviews used a version of the
Schedule for Affective Disorders and Schizophrenia for School-Age Children (K-SADS)
(26), combining features of the Epidemiologic and Present Episode versions. T4 used the
Structured Clinical Interview for DSM–IV (SCID) (27). Diagnoses were based on DSM-III-
R criteria at T1 and T2 and DSM-IV criteria at T3 and T4. The T1 interview recorded
lifetime disorders from the age of 5. In T2-T4 interviews, the Longitudinal Interval Follow-
Up Evaluation (LIFE) (28) assessed psychopathology since the previous interview.
Clinical characteristics were collected from diagnostic interviews. Disorder duration was
calculated as the cumulative duration of MDD and AUD episodes in weeks. Disorder
severity was defined as the lifetime occurrence of severe depression for MDD based on the
DSM episode specifier and lifetime occurrence of alcohol dependence as opposed to abuse
only for AUD. By T4, 121 AUD participants had a lifetime alcohol abuse diagnosis only
(42.9%), 113 had a lifetime dependence diagnosis only (40.1%), and 48 had both lifetime
diagnoses (17.0%). Lifetime suicide attempts and mental health treatment were assessed
using relevant sections of the K-SADS and SCID. Psychosocial outcomes at T4 included
marital status (1=not married; 0=married), parental status (1=never parent; 0=parent), years
of schooling completed, weeks of unemployment in the past year, annual household income,
global functioning (GAF; DSM-III-R/-IV), self-rated physical health (4-item scale; α=0.50),
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life satisfaction (15-item scale; α=0.89), and past-year risky sexual behavior (1=any report
of risky sex on 9 items; 0=none).
Statistical Analyses
We examined comorbidity between MDD and AUD in three developmental periods:
Adolescence (two years prior to T1 up to and including T2); Early Adulthood (immediately
after T2 up to and including T3); and Adulthood (immediately after T3 up to and including
T4). We used path analysis to evaluate associations between MDD and AUD across periods.
We specified a cross-lagged model with 1) cross-sectional associations between MDD and
AUD in each period, 2) continuity associations for each disorder between adjacent periods,
and 3) prospective associations from one disorder to the other in adjacent periods. Anxiety
disorders, Disruptive behavior disorders, and other Substance use disorders were used as
controls in adolescence. We used probit regressions to evaluate associations between
disorders over time in Mplus 6.21 (29). Acceptable model fit (CFI and TLI >=0.90;
RMSEA<=0.08)(30) was validated before examining individual paths. We examined
differences between comorbid and pure disorders on clinical and psychosocial impairments
using linear or logistic regression adjusting for sex, anxiety disorders, DBD, and other SUD
by T4. We evaluated differences as a function of temporal ordering, concurrency, or the
ordering x concurrency interaction separately. Temporal ordering was coded as MDD-First,
AUD-first or simultaneous onset based on the month of onset of the first lifetime MDD and
AUD episodes. Concurrent comorbidity was coded as any history of overlapping MDD and
AUD episodes by age 30, while successive comorbididy was coded as no history of
overlapping MDD and AUD episodes by age 30. We used T3 sampling weights in all
analyses.
Results
Period and Cumulative Prevalence
Table 1 presents the prevalence of pure and comorbid MDD and AUD by developmental
period. Rates of pure MDD were already high in adolescence and remained relatively
constant at approximately 20% over each period. Rates of pure AUD and comorbid MDD
+AUD were low (below 5%) in adolescence, but escalated to 10-21% in early adulthood,
before leveling down to 5-18% in adulthood. Patterns of MDD and AUD differed by sex in
all periods (Chi square, p < .001): pure MDD was more prevalent in women, whereas pure
AUD and no disorder were more prevalent in men. The only exception was pure AUD in
adolescence, which did not differ by sex. Interestingly, rates of comorbid MDD+AUD did
not differ by sex in any period.
The bottom portion of Table 1 shows the cumulative rates of pure and comorbid MDD and
AUD by T4. Comorbid MDD+AUD remained less prevalent than pure MDD by age 30, but
was more prevalent than pure AUD. Consistent with developmental periods, rates differed
by sex (Chi square, p < .001), with higher rates of pure MDD in women and higher rates of
no disorder and pure AUD in men. Cumulatively, 40% of participants with lifetime MDD
had a history of AUD and 59% of individuals with lifetime AUD had a history of MDD. The
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cumulative association between disorders was moderate in magnitude (OR=1.6,
95%CI=1.2–2.1) and did not differ by sex.
Comorbidity as A Function of Temporal Ordering and Concurrency
We next examined temporal ordering and concurrency of MDD and AUD in individuals
with cumulative comorbidity by T4. MDD occurred before AUD in 57% of individuals with
comorbid disorders. AUD occurred first in the remaining 41% of cases, except for rare
instances of simultaneous onset (2%). Cumulative MDD+AUD comorbidity was equally
divided between concurrent and successive comorbidity (51% v. 49%). Figure 1 depicts the
proportion of comorbid subtypes as a function of lifetime temporal ordering and
concurrency.
We also investigated temporal ordering specifically in concurrent MDD+AUD. We
considered the first concurrent episode in individuals with multiple episodes to avoid
dependency. In contrast to lifetime temporal ordering, AUD occurred first in 57% of
concurrent episodes; MDD occurred first in 23% of concurrent episodes and simultaneous
onset represented the remaining 20% of concurrent episodes. In the majority of cases (62%),
concurrent episodes developed after one or more previous non-concurrent episode(s) of
MDD or AUD. Thirty percent of concurrent episodes were preceded by MDD only, 11%
were preceded by AUD only, and 21% were preceded by non-concurrent episodes of both
MDD and AUD.
Associations Between Disorders Across Periods
Figure 2 presents the cross-sectional and prospective associations between MDD and AUD
over time, adjusting for adolescent anxiety disorder, DBD, and other SUD. MDD and AUD
were moderately stable over time, with two significant interactions by gender. Adolescent
AUD was predictive of early adult AUD for women but not men, and early adult MDD was
more predictive of adult MDD in men than women, though continuity for both sexes was
significant. MDD and AUD were associated in every period. AUD in adolescence was
predictive of MDD in early adulthood, but not from early adulthood to adulthood.
Conversely, MDD in early adulthood was predictive of AUD in adulthood, but not from
adolescence to early adulthood. Cross-sectional and prospective associations between the
two disorders did not vary by sex.
Cumulative Lifetime Clinical Characteristics
Table 2 presents analyses comparing lifetime clinical characteristics in pure and comorbid
MDD and AUD, adjusting for sex and cumulative anxiety disorder, DBD, and other SUD.
Comorbidity was not associated with greater MDD or AUD duration or depression severity.
Conversely, comorbid MDD+AUD was associated with greater AUD severity (i.e., alcohol
dependence). Two-thirds of participants with comorbid MDD+AUD had alcohol
dependence compared to less than half of pure AUD participants. A similar pattern emerged
for mental health treatment: individuals with comorbid MDD+AUD did not differ from
individuals with pure MDD, but were approximately three times more likely to receive
treatment than individuals with pure AUD. Comorbid MDD+AUD was associated with
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greater odds of lifetime suicide attempt than both pure MDD, by twofold, and pure AUD, by
sevenfold.
We also examined clinical characteristics in comorbid subtypes based on temporal ordering
and concurrency. Concurrency and temporal ordering interacted in predicting MDD duration
(B=90.6, 95%CI=22.8–158.4). Follow-up analyses indicated that participants with
concurrent MDD+AUD and MDD-First had strikingly longer cumulative lifetime duration
of MDD episodes (median=95.5 weeks) than participants in all other comorbid groups, as
well as the pure MDD group (median duration for all other groups=15.9–24.0 weeks).
Conversely, duration of AUD episodes varied as a function of concurrency but not temporal
ordering. Follow-up analyses indicated that duration of AUD episodes was higher in the
concurrent group (median=182.0 weeks) than in the successive group (median=91.6 weeks)
(B=86.3, 95%CI=41.5–131.1), but not in the pure AUD group (median=132.0 weeks).
Duration was higher in the pure AUD group than the successive group (B=57.0,
95%CI=10.8–103.2). MDD and AUD severity did not differ by temporal ordering or
concurrency. Finally, risk of suicide attempt varied as a function of temporal ordering. Odds
of suicide attempt were greater in MDD-First (34.5%) than AUD-First (19.2%) (OR=2.2,
95%CI=1.0–4.7), pure MDD (13.3%) (OR=3.4, 95%CI=2.0-6.0), and pure AUD (3.7%)
(OR=9.4, 95%CI=3.2–27.7). Odds of suicide attempt were also higher for the AUD-First
group compared to pure AUD (OR=4.1, 95%CI=1.3–13.3).
Psychosocial Outcomes At Age 30
Table 3 shows the psychosocial outcomes at age 30 (T4) of lifetime pure and comorbid
MDD and AUD, adjusting for sex and lifetime anxiety disorder, DBD, and other SUD.
Comorbid MDD+AUD was predictive of lower global functioning and life satisfaction than
both pure MDD and pure AUD. MDD+AUD was also associated with greater odds of being
unmarried compared to pure MDD, but not pure AUD. MDD+AUD comorbidity did not
differ from pure disorders on other psychosocial outcomes. Last, a comorbidity × gender
interaction (B=0.08, 95%CI=.001–0.15) indicated that MDD+AUD was associated with
lower unemployment than pure MDD in men (B=-0.08. 95%CI =-0.15–-0.02), but not
women.
Examination of comorbid subtypes revealed few differences. Compared to successive
comorbidity, concurrent comorbidity was associated with lower global functioning (B=-3.7,
95%CI=-7.3–-0.03). Follow-up analyses indicated that both concurrent (B=-6.9,
95%CI=-10.2–-3.6) and successive (B=-3.4, 95%CI=-6.7–-0.1) comorbidity were associated
with lower functioning than pure AUD, but only concurrent comorbidity was associated
with lower functioning than pure MDD (B=-6.6, 95%CI=-9.6–-3.6). Concurrent comorbidity
was also associated with higher odds of risky sexual behavior than successive comorbidity
(OR=2.4, 95%CI=1.2–4.8). Follow-up analyses indicated that concurrent, but not
successive, comorbidity increased the odds of risky sex relative to pure MDD (OR=2.1,
95%CI=1.1–3.8).
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Discussion
To our knowledge, the present study represents the most comprehensive examination of the
development and cumulative outcomes of comorbidity between MDD and AUD provided by
a prospective study. Our study confirms the significant comorbidity between mood and
alcohol use disorders reported (1-3), but extends previous findings in several important
ways. First, we find considerably higher lifetime prevalence rates of MDD+AUD than
previous epidemiological studies. One out of five participants reported a history of
comorbidity by age 30, compared to much lower rates in other studies (e.g., 4%) (18). This
difference is likely to mostly reflect under-reporting of disorder rates in retrospective studies
(31), but could also be related to the use of full review of past periods between assessments,
the use of semistructured rather than structured interviews, and K-SADS and SCID
definitions for MDD and AUD symptom thresholds. Although the OADP population may
over-represent White populations, multiple assessements combined with full coverage of
past periods is likely to provide amongst the most accurate picture of cumulative disorder
rates as can be found in available representative prospective samples (32). Second, we find
that by age 30, comorbidity represents the majority of cases in women with a history of
AUD and men with a history of MDD, as well as approximately half of cases in men with a
history of AUD. Clearly, comorbidity is normative rather than an exception in individuals
with either disorder, except for women with a history of MDD. Third, we found comorbidity
to be rare in adolescence (mostly due to low rates of AUD), but already elevated by early
adulthood. Rates of period comorbidity were highest in early adulthood and the majority of
individuals with AUD already had a history of MDD by that time. Fourth, we found roughly
equal lifetime rates of concurrent and successive comorbidity by age 30. In most cases,
concurrent episodes developed after remission from non-concurrent episode(s) of MDD,
AUD, or both. This novel finding suggests that concurrency tends to occur at a later stage in
a trajectory of successive comorbidity.
A key focus of this study was on the relation between MDD and AUD over time. We first
examined temporal ordering. Consistent with previous studies (1, 7, 8), we found that MDD
tended to occur prior to AUD (57% of lifetime cases). Only 2% of lifetime cases had a
simultaneous onset of first incidence MDD and AUD, reinforcing the notion of concurrent
comorbidity as an end-stage phenomenon. Interestingly, we found the converse pattern when
examining temporal ordering in concurrent episodes specifically: AUD tended to occur first
in the majority of concurrent episodes (57%) and MDD occurred first in only 23% of
concurrent episodes. We also examined prospective associations between MDD and AUD
over time. We jointly considered cross-sectional and prospective associations across the
three developmental periods, adjusting for disorder stability over time and potential
psychiatric confounds. We found AUD in adolescence to predict MDD in early adulthood,
but not the reverse. Conversely, we found MDD in early adulthood to predict AUD in
adulthood, but not the reverse.
Taken together, these findings suggest that MDD and AUD relate in a complex manner.
Multiple explanations have been proposed to explain comorbidity between heterotypic
psychiatric disorders (6): 1) comorbidity represents a marker for the severity of relatively
undifferentiated symptoms, 2) one disorder is a manifestation of the other, 3) one disorder
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causes the other, 4) two disorders share common causes, and 5) comorbidity is a marker for
a unique disorder subtype. The present results suggest that several mechanisms may apply to
comorbid MDD+AUD. The greater temporal precedence of MDD in individuals with
lifetime MDD+AUD is consistent with a potential causal effect of MDD on AUD, but does
not preclude other explanations. For instance, as MDD and AUD relate to separate but
correlated liabilities for Internalizing and Externalizing traits respectively (33), shared
vulnerability for these two traits could explain why the disorders are linked despite emerging
at different times. On the other hand, the greater temporal precedence of AUD in concurrent
episodes may reflect different etiologic processes. This pattern is consistent with a proximal
causal effect of AUD on the development of MDD, but could also index some MDD
episodes as manifestations of AUD or a subtype of alcohol-induced MDD (34).
Prospective associations across developmental periods are the strongest evidence in favor of
a causal relation between MDD and AUD. Our findings suggest modest, bidirectional, and
developmentally-specific associations between the two disorders. This finding is broadly
consistent with studies showing AUD to predict MDD (12, 13), MDD to predict AUD (8,
11) or both (9, 14, 15). Mixed results from previous studies could be partly due to a failure
to account for developmental timing. Adolescent AUD may contribute to MDD risk in early
adulthood by bringing about negative psychosocial consequences that are developmentally
salient as adolescents move into adulthood (e.g. academic difficulties). Conversely, early
adult MDD may contribute to the risk of AUD in adulthood via a “self-medication”
mechanism (35) emerging specifically as individuals mature. However, it should be noted
that self-medication is most consistent with AUD occurring after MDD in concurrent
episodes as an attempt to cope with depressive symptoms, a pattern which we did not
frequently observe. This raises the possibility that a mechanism other than self-medication
mediates long-term associations.
Another focus of this study was on sequala of cumulative comorbidity. Contrary to
expectation, we did not find lifetime MDD+AUD to be broadly associated with more
clinical and psychosocial impairments than pure disorders. Nonetheless, we did identify
several key negative correlates of comorbidity. We confirm the well-established finding (4,
18) that comorbidity increases the risk of suicide attempts, especially in individuals with
AUD. Comorbidity also more than doubled the risk of alcohol severity, as defined by the
presence of alcohol dependence, compared to pure AUD. This result is consistent with
recent studies showing stronger comorbidity between MDD and alcohol dependence than
abuse (1, 3, 15). Although the two alcohol use disorders are merged into a single diagnosis
in DSM-5 (24), our findings paired with previous research suggest that alcohol dependence
symptoms should remain a valuable marker in research on comorbidity with depression.
Also consistent with previous studies (4), we found comorbidity to be associated with poorer
functioning and life satisfaction than pure MDD and AUD.
Several interesting differences between comorbid subtypes emerged in terms of clinical
characteristics and psychosocial outcomes. Like others (18), we found MDD-first
comorbidity to be associated with increased depression duration and suicidality compared to
other comorbid groups and pure MDD. However, MDD duration was specifically increased
when MDD-first was paired with concurrent comorbidity, with increased duration likely
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reflecting more MDD episodes in concurrent (mean=2.9) vs. other comorbid subtypes
(means=1.8–2.0). One possibility is that a subset of individuals with a history of recurrent
and more chronic depression are at risk of eventually developing an alcohol use disorder,
which may represent an unsuccessful attempt to cope with mood symptoms that serves to
maintain or exacerbate depression over time. Successive comorbidity was also associated
with fewer problematic outcomes (functioning, risky sexual behaviors, AUD duration) than
concurrent comorbidity.
Limitations
Study limitations should be noted. First, we combined diagnoses of alcohol abuse and
dependence for most analyses. This approach did not allow us to investigate the specific
importance of dependence symptoms (1, 3, 15) and use of a broad definition may increase
the possibility of conflicting findings across studies (36). On the other hand, our approach is
consistent with DSM-5 (24) and is supported by the facts that alcohol abuse is hard to
diagnose reliably and that diagnoses of abuse and dependence tend to form a single latent
dimension (37). Another justification for examining a single diagnostic category is that more
than a quarter (28%) of individuals in the AUD group had a history of both diagnoses by age
30. Second, our design was not fully prospective. Using prospective assessments paired with
recall allowed us to have full diagnostic coverage from adolescence to adulthood, but this
strategy still involved a degree of recall bias. Third, the OADP dataset is not fully
representative and particularly over-represents White participants. Fourth, we used OADP
weights to adjust for missing data by design, but did not correct for potential attrition bias
using approaches such multiple imputation or maximum likelihood estimation.
Implications
Several directions for future research can be suggested from this study. More prospective
studies are needed, especially research examining risk factors (e.g., temperamental
dispositions, early life experiences, neurobiological characteristics) that prospectively
anticipate comorbid MDD+AUD. Theoretically, etiological models on MDD+AUD should
be refined to take into account developmental factors, including concurrency and
developmental timing. With regards to nosological models, our findings on concurrent
disorders support the potential relevance of an alcohol-induced depression subtype.
The present findings also have important implications for clinical practice with both
adolescents and adults. Our research re-emphasizes that treatment should always start with a
comprehensive assessment of current and past psychopathology. As most adults with MDD
or AUD will have a history of other disorder (except perhaps women with MDD), clinicians
should inquire about both disorders with a special attention for symptoms of alcohol
dependence, even under the new DSM-5. Treatment recommendations exist and should be
used when addressing concurrent comorbidity (38). Whether and how treatment should be
modified in cases of successive comorbidity is an understudied area that requires further
attention. The developmental associations between MDD and AUD emphasize the
importance of developmental timing in prevention. Intervening in AUD during adolescence
may help to prevent future MDD and intervening in MDD early adulthood may help to
prevent subsequent AUD.
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Figure 1. Subtypes of Cumulative Lifetime Comorbidity between MDD and AUD as a Function
of Concurrency and Temporal Ordering
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Figure 2. Overall and Gender-Specific Associations between MDD and AUD from Adolescence
to Adulthood
Model fit: CFI=0.982; TLI=982; RMSEA=0.022. Associations are standardized regression
coefficients. Full lines represent gender invariant associations. Dashed arrows represent
gender specific associations. The model adjusts for anxiety disorders, disruptive behavior
disorders, and other substance use disorders in adolescence (not shown). Controls were
specified to predict MDD and AUD in early adulthood and adulthood and to correlate
together and with MDD and AUD in adolescence.
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Table 1
Weighted Period and Cumulative Prevalence of Pure and Comorbid MDD and AUD
n (%)
Pure MDD Pure AUD MDD+AUD
Adolescence
Women 109 (23.8) 10 (2.2) 9 (2.0)
Men 33 (9.2) 16 (4.5) 6 (1.7)
Total 142 (17.4) 26 (3.2) 15 (1.8)
Early Adulthood
Women 134 (29.3) 48 (10.5) 48 (10.5)
Men 40 (11.2) 77 (21.5) 39 (10.9)
Total 174 (21.3) 125 (15.3) 87 (10.7)
Adulthood
Women 127 (27.8) 25 (5.5) 36 (7.9)
Men 35 (9.8) 63 (17.6) 19 (5.3)
Total 162 (19.8) 89 (10.9) 55 (6.7)
Lifetime
Women 203 (44.3) 34 (7.3) 94 (20.5)
Men 51 (14.2) 81 (22.8) 74 (20.6)
Total 254 (31.1) 115 (14.1) 167 (20.5)
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